Rethymic Implant

RxCUI
2626469
RxNorm name
Rethymic Implant
Display name
Rethymic Implant
Full name
Rethymic Implant
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125685Rethymicallogeneic processed thymus tissue-agdc351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RETHYMICALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDCSumitomo Pharma America, Inc.e0022c28-8cda-4f1e-bcf1-1f440d37ec4a2025-10-31Warnings, Adverse reactionsExact identifier
rxcui: 2626469

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e0022c28-8cda-4f1e-bcf1-1f440d37ec4aRETHYMIC Implant [PSN] · allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant [Rethymic] [SBD] · Rethymic 22,000 mm2 Implant [SY] · Rethymic 220 SQCM Implant [SY] · Rethymic Implant [SY]58These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 202120251031